WL
Wei Lee Lim
View Wei's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
N/A
Jul 2023 - Present · 1 years and 5 months
N/A
Apr 2022 - Jul 2023 · 1 years and 3 months
Technical University of Munich
N/A
Jul 2019 - Jul 2022 · 3 years
Company Details
51-200 Employees
Medigene AG (FSE: MDG1) is a leading immuno-oncology platform company dedicated to developing T-cell therapies to effectively eliminate cancer. Its end-to-end technology platform is built on multiple proprietary exclusive product development and product enhancement technologies, and allows Medigene to create best-in-class differentiated, T cell receptor engineered T cell (TCR-T) therapies for multiple solid tumor indications that are optimized for both safety and efficacy. This platform provides product candidates for both its in-house therapeutics pipeline and partnering. For more information, please visit www.medigene.com
Year Founded
1994
Social Media
LinkedinTwitter
Industry
Biotechnology Research, Pharmaceutical products, Medical and pharmaceutical research, Research and testing, IT, Internet, R&D, Pharmaceuticals research and development, Pharmaceutical preparations for the central and autonomic nervous system and anaesthetics, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Pharmaceutical preparations for the cardiovascular system
HQ Location
--
Keywords
Immunotherapies and T Cell receptors TCRencephalitis vaccinedevelop cellulartumor cellinnovative vaccineimprovement clinical developmentcell killing effectsimprovement clinicalprocess improvement clinicaltreatment platforms
Discover More About Cleveland Clinic

Find verified contacts of Wei Lee Lim in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.